Medpace Holdings (NASDAQ:MEDP) will report earnings after market hours, with analysts expecting revenue to grow 2.6% YoY to $542 million and adjusted earnings at $3.00 per share. The company beat revenue expectations by 6% last quarter, with impressive organic revenue and EPS beats. Analysts have largely reconfirmed estimates, despite Medpace missing revenue estimates five times in the past two years. The life sciences sector has been down, but Medpace’s stock price remains steady. As the first in its sector to report earnings this season, all eyes are on Medpace. Check out the free report on a fast-growing enterprise software stock riding the automation wave.

Read more at StockStory Corp.: Medpace (MEDP) Q2 Earnings Report Preview: What To Look For